British Journal of Cancer · 2010 · 27 citations · 20 references
Life SciencesImmunologyInfectious DiseasesCancer ImmunologyClinical ImmunologyMolecular VirologyAntiviral ImmunityCell-mediated ImmunityImmune ResponseInterferon ResponsesT Cell BiologyViral PathogenesisAnti-viral ImmunityAntiviral T Cell ResponsesCellular Immune Response To VirusesInterferon Gamma ResponseInterferon-gamma ResponsesVaricella-zoster Virus InfectionsVaricella-zoster Virus Reactivation
BACKGROUND: Reactivation of the varicella zoster virus (VZV) is more common in patients with malignancies; however, the molecular and cellular mechanisms underlying this susceptibility are unclear. METHODS: Using ex vivo interferon-gamma ELISpot assays, we set out to analyse VZV-specific immune responses in a large cohort of patients with malignancies. RESULTS: We observed that patients with malignancies had impaired VZV-specific T-cell responses, particularly in those with haematological malignancies and breast carcinoma. Immediate-early protein 63 (IE63)-specific T-cell responses were significantly impaired in those with subclinical VZV re-activation. CONCLUSIONS: Our results suggest that T-cell responses to IE63 are important in controlling VZV replication.
20
Myron J. Levin, Jeffrey G. Smith, Robin M. Kaufhold et al. · The Journal of Infectious Diseases · 2003 · 320 citations · Full text
Jeffrey G. Smith, Xu Liu, Robin M. Kaufhold et al. · Clinical and Diagnostic Laboratory Immunology · 2001 · 180 citations · Full text